Dramatic down-regulation of oxidoreductases in human hepatocellular carcinoma hepG2 cells: proteomics and gene ontology unveiling new frontiers in cancer enzymology
2008
Down-Regulation of Oxidoreductases in Liver Cancer Cells
publication
Evidence: moderate
Author Information
Author(s): Ngoka Lambert CM
Primary Institution: Virginia Commonwealth University
Hypothesis
Are oxidoreductase enzymes down-regulated in HepG2 cells compared to normal human liver tissues?
Conclusion
The study found that oxidoreductase enzymes are down-regulated in HepG2 cells by approximately 57% compared to normal human liver tissues.
Supporting Evidence
- Oxidoreductase activity in HepG2 cells was found to have 188 annotated protein sequences compared to 331 in normal liver.
- Annotation scores indicated a significant reduction in oxidoreductase activity in HepG2 cells.
Takeaway
This study shows that important enzymes that help protect cells from damage are much lower in liver cancer cells than in healthy liver cells.
Methodology
The study used proteomics and Gene Ontology mapping to analyze enzyme expressions in HepG2 cells and normal liver tissues.
Limitations
The study primarily used a cell line (HepG2) which may not fully represent in vivo conditions of liver cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website